Showing results (201-210 of 323) with videos related to

Sort By:
Pageof 33
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 28, 2013
The effect of anticoagulant therapy for idiopathic pulmonary fibrosis in real life practiceS Tomassetti, J H Ruy, C Gurioli, et al.
The European Respiratory Journal. Supplement|January 31, 2002
Interstitial lung diseases: an epidemiological overviewM Demedts, A U Wells, J M Antó, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patientsP L Zinzani, M Magagnoli, P Galieni, et al.
Respiratory Research|March 24, 2024
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature reviewA Damiani, M Orlandi, C Bruni, et al.
Histopathology|August 30, 2008
Interobserver variation in the classification of thymic tumours--a multicentre study using the WHO classification systemE T Verghese, M A den Bakker, A Campbell, et al.
British Journal of Cancer|November 17, 2005
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patientsF Cappuzzo, L Toschi, I Domenichini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibF Cappuzzo, L Toschi, G Tallini, et al.
ESMO Open|August 30, 2025
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinibE Vita, A Scala, A Vitale, et al.
Respiratory Medicine|May 13, 2015
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life studyS Harari, A Caminati, C Albera, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 16, 2024
Update to RIFM fragrance ingredient safety assessment, 2-methyl-4-phenylbutyraldehyde, CAS Registry Number 40654-82-8A M Api, A Bartlett, D Belsito, et al.
Pageof 33